Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00467ApprovedSmall molecule
A broad-spectrum 6-fluoronaphthyridinone antibacterial agent (fluoroquinolones) structurally related to nalidixic acid.
- Mechanism
- Curator reviewed
Enoxacin exerts its bactericidal action via the inhibition of the essential bacterial enzyme DNA gyrase (DNA Topoisomerase II).
- Primary indication
- For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract...Curator reviewed
- Formula / weight
- C15H17FN4O3 · 320.3189 g/mol (avg)
- Code names
- AT-2266 · CI-919 · PD-107779
Resolves to
Clinical / RWD
Structure
InChIKey
IDYZIJYBMGIQMJ-UHFFFAOYSA-NSMILESCCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1What you can answer from here — as of September 23, 2026
7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Enoxacin, and which of those have an active Phase 3 trial?